Further underlining the clinical relevance of SAA proteins in the context of metastasis, SAA levels in PDAC and NSCLC patients were elevated in the presence of liver metastasis as compared to normal donors or patients with locally advanced tumors (Lee et al. 2019). Here, SAA1 is linked to non-small cell lung carcinoma.